MCL-1 inhibitor ABBV-467
Term · Oncology and biomedicine · MLC-T-ONC-015030
An inhibitor of induced myeloid leukemia cell differentiation protein (myeloid cell leukemia-1; Mcl-1; Bcl2-L-3), with potential pro-apoptotic and antineoplastic activities. Upon administration, MCL-1 inhibitor ABBV-467 targets and binds to Mcl-1, thereby preventing the binding of Mcl-1 to and inactivation of certain pro-apoptotic proteins. This promotes apoptosis of cells overexpressing Mcl-1. Mcl-1, an anti-apoptotic protein belonging to the B-cell lymphoma 2 (Bcl-2) family of proteins, is upregulated in cancer cells and promotes tumor cell survival.
| Identifier | MLC-T-ONC-015030 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | myeloid cell leukemia-1 inhibitor ABBV-467 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015030",
"term": "MCL-1 inhibitor ABBV-467",
"field": "Oncology and biomedicine",
"definition": "An inhibitor of induced myeloid leukemia cell differentiation protein (myeloid cell leukemia-1; Mcl-1; Bcl2-L-3), with potential pro-apoptotic and antineoplastic activities. Upon administration, MCL-1 inhibitor ABBV-467 targets and binds to Mcl-1, thereby preventing the binding of Mcl-1 to and inactivation of certain pro-apoptotic proteins. This promotes apoptosis of cells overexpressing Mcl-1. Mcl-1, an anti-apoptotic protein belonging to the B-cell lymphoma 2 (Bcl-2) family of proteins, is upregulated in cancer cells and promotes tumor cell survival.",
"synonyms": [
"myeloid cell leukemia-1 inhibitor ABBV-467"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/mcl-1-inhibitor-abbv-467/"
}
Record 10,692 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.